Evidence map›Paper›PMID 29992137›Full record

ArticleBioMed research international2018

Recep Dursun, Hatice Gül Dursun, Ayşe Gül Zamani, Mahmut Selman Yıldırım, İlknur Çınar

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Recep DursunDepartment of Dermatology, Meram Faculty of Medicine, Necmettin Erbakan University, 42080 Konya, Turkey.ORCID 0000-0002-1279-574X
Hatice Gül DursunDepartment of Medical Biology, Meram Faculty of Medicine, Necmettin Erbakan University, 42080 Konya, Turkey.ORCID 0000-0001-5115-4681
Ayşe Gül ZamaniDepartment of Medical Genetics, Meram Faculty of Medicine, Necmettin Erbakan University, 42080 Konya, Turkey.
Mahmut Selman YıldırımDepartment of Medical Genetics, Meram Faculty of Medicine, Necmettin Erbakan University, 42080 Konya, Turkey.
İlknur ÇınarDepartment of Medical Biology, Meram Faculty of Medicine, Necmettin Erbakan University, 42080 Konya, Turkey.
Necmettin Erbakan University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a common, chronic, and autoimmune skin disease. Factors that play a role in etiopathogenesis of psoriasis include internal factors such as genetic susceptibility and immunological factors and external factors such as stress, infection, trauma, drug, and environmental compounds. N-acetyltransferase 2 (NAT2) is a xenobiotic enzyme that is involved in the metabolism of drugs, environmental toxins, and carcinogens. In this study, we aimed to demonstrate whether the variations in the

Indexed as

AdultArylamine N-AcetyltransferaseCase-Control StudiesFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansIranMaleMiddle AgedPolymorphism, GeneticPolymorphism, Single NucleotidePsoriasisYoung AdultArylamine N-AcetyltransferaseNAT2 protein, human

Identifiers

PMID29992137
PMCPMC6016222
OpenAlexW2808559105

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.